This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
AT Europe 2019: Scientific Program
Share |

 

To view the preliminary program, click here

 

           

Session Information

Wednesday, 13 March, 2019

Keynote I Session

Post-approval Flexibility in Analytical Methods
Seàn Barry, Health Products Regulatory Authority (HPRA), Dublin, Ireland

 

Mass Spectrometry Session

Direct Quality Control of Glycoengineered Erythropoietin Variants
Tomislav Čaval, Utrecht University, Utrecht, Netherlands 

Characterization of New Antibody-derived Therapeutics at the Intact and Middle-up Level using Sheathless CE-MS
Elena Dominguez-Vega, Leiden University Medical Center, Leiden, Netherlands

Can Low Resolution MS Generate High-quality MAM data and replace high resolution MS for Process Development Support?  
Scott Corley, Boehringer Ingelheim, Inc., Fremont, CA USA

 

Capillary Electrophoresis Session

Extending the Range - Affinity Capillary Electrophoresis in Charge Heterogeneity Profiling
Steffen Kiessig, F. Hoffmann - La Roche Ltd., Basel, Switzerland

TBD
Jeff Beckman, Bristol-Myers Squibb Company, Devens, MA USA

 

Thursday, 14 March, 2019

Keynote II Session

Strategies for the Separation of Complex Samples
Peter Schoenmakers, Universiteit van Amsterdam, Amsterdam, Netherlands

 

Liquid Chromatography Session 

On the Versatility of 2D-LC in Biopharmaceutical Analysis
Koen Sandra, Research Institute for Chromatography, Kortrijk, Belgium

High-Throughput, Multi-Attribute Continuous Product Characterisation Platform for Increased Process Control Monitoring
Noemi Dorival-Garcia, NIBRT, Dublin, Ireland

 

HCP Session

The Increasing Need to use Mass Spectrometry to Identify and Monitor HCPs in Biologics
Severine Clavier, Vitry-sur-seine, Paris, France

Host Cell Proteins: Current Strategies and Future Directions
Markus Haindl, F. Hoffman - La Roche Ltd., Penzberg, Germany

MS-based HCP Testing Strategy for a Vaccine Manufactured in a Novel Cell Line
Annemiek Verwilligen, Janssen Vaccines & Prevention, Leiden, Netherlands

Identification and Quantification of Polysorbate-degrading Host Cell Protein Impurities in Biopharmaceuticals using Advanced Mass Spectrometry-based Techniques
Michael Zorn, Boehringer Ingelheim Pharma GmbH & Co. KG, Ulm, Germany

 

Friday, 15 March, 2019

Keynote III Session

Bioanalysis of Biopharmaceuticals by Liquid Chromatography - Mass Spectrometry
Rainer Bischoff, University of Groningen, Groningen, Netherlands

 

Structure-Function Studies Session

Picking-up Product Degradation by Bioassay. Function and Structure… Pieces of the Puzzle
Annemie Welant, UCB Pharma, Brussels, Belgium

TBD
Mark Drew, AstraZeneca, Cheshire, United Kingdom

Comparability Studies of Pharmaceutical Proteins by 2D NMR Fingerprint
Joan Malmstrøm, Novo Nordisk A/S, Måløv, Denmark

 

Regulatory Session

European Pharmacopoeia - Recent Developments in the Field of Biopharmaceuticals
Olga Kolaj-Robin, EDQM, Strasbourg, France

TBD
Joel Welch, CDER, FDA, Silver Spring, MD USA

Biopharmaceuticals – A Regulatory Update
Maeve Lally, Health Products Regulatory Authority (HPRA), Dublin, Ireland

 

 

 


 

more Calendar

2/12/2019 » 3/1/2019
WCBP 2019 On-Demand Stream

3/12/2019 » 3/13/2019
CMC Strategy Forum Latin America 2019

3/12/2019 » 3/15/2019
AT Europe 2019

Featured Members
William Weiss, Eli Lilly and CompanyFind out more about Will in this month's Member Spotlight!

Membership Software Powered by YourMembership  ::  Legal